Business Context and Reporting Period
This Form 8-K filing by Griffin-American Healthcare REIT IV, Inc. (American Healthcare REIT, Inc.) reports on events occurring on December 31, 2017. The registrant is an emerging growth company incorporated in Maryland, with principal executive offices in Irvine, California. The filing details the execution of executive stock purchase plans by key management personnel.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial figure disclosed is the share purchase price of $9.21 per share for Class I common stock, which reflects the price in the company's public offering.
Material Changes
On December 31, 2017, the following material changes regarding executive compensation and equity ownership were executed:
- Executive Stock Purchase Plans: Jeffrey T. Hanson (Chairman/CEO), Danny Prosky (President/COO), and Mathieu B. Streiff (EVP/General Counsel) agreed to invest 100% of their net after-tax base salary and cash bonus earned on or after January 1, 2018, into Class I common stock.
- Stock Purchase Plans: Four Executive Vice Presidents, including Brian S. Peay (CFO) and Stefan K.L. Oh (EVP of Acquisitions), agreed to invest between 5% and 15% of their net after-tax base salary (and/or cash bonus) into Class I common stock.
- Implementation: Purchases commenced with the first payroll on January 22, 2018, at a price of $9.21 per share. No selling commissions, dealer manager fees, or stockholder servicing fees were paid on these transactions.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on market outlook, or specific risk factors. The stock purchase plans are set to terminate on December 31, 2018, or earlier upon the occurrence of certain events, such as the termination of the public offering of securities, unless renewed or extended.
Investor Verification Checklist
- Verify the total number of shares purchased by executives under these plans in subsequent filings.
- Confirm the status of the public offering of securities to determine if the plans terminated early.
- Review the company's prospectus or S-11 filing for details on the $9.21 share price and the structure of the public offering.
- Monitor future 8-K filings for any renewal or extension of the stock purchase plans beyond December 31, 2018.